FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost-Effectiveness Analysis.
Brendan CollinsChristodoulos KypridemosJonathan Pearson-StuttardYue HuangPiotr BandoszParke WildeRogan KershSimon CapewellDariush MozaffarianLaurie P WhitselRenata MichaMartin O'Flahertynull nullPublished in: The Milbank quarterly (2019)
The benefits of implementing the FDA voluntary sodium targets extend to food companies and food system workers, with the value of health gains and health care cost savings outweighing the costs of reformulation, although not for the processed food industry.